TABLE 1.
Summary of MALDI-TOF analysis of biotinylated XPA peptides
Presented are tryptic digest fragments containing biotinylated lysine residues. Lysine residues protected from modification in the presence of ATR are indicated by a +, whereas residues not protected by ATR are indicated by a −. The asterisk indicates that the biotinylated fragment is located in the His tag. The intensity of the biotinylated peptide peak 184–189 (Lys-188 + biotin) was at least 10-fold higher for free XPA treated with NHS-biotin than for XPA-ATR complex modified under identical conditions. Intensities of other biotinylated XPA peptide fragments in the absence and presence of ATR varied within ±20%.
| Fragment | Modified Lys | Protection |
|---|---|---|
| (−18)–(−5)* | −12* | − |
| 31–32 | 31 | − |
| 87–110 | 89 | − |
| 136–141 | 137 | − |
| 152–158 | 157 | − |
| 164–168 | 167 | − |
| 184–189 | 188 | + |
| 190–207 | 204 | − |
| 218–221 | 218 | − |
| 216–221 | 217, 218 | − |
| 219–224 | 221, 222 | − |
| 222–227 | 222, 224 | − |
| 223–227 | 224 | − |
| 232–237 | 236 | − |
| 259–273 | 259 | − |
| 260–273 | 272 | − |